Medicine guide

VidPrevtyn Beta

·

  • Prescription status not stated
  • Antibiotics, antivirals and antifungals taken into the body
Made by
Sanofi Pasteur

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • VidPrevtyn Beta is indicated as a booster for active immunisation to prevent COVID-19 in adults who have previously received an mRNA or adenoviral vector COVID-19 vaccine (see sections 4.2 and 5.1 in product information document). The use of this vaccine should be in accordance with official recommendations.

From the official label · 2026-09-30 · European Medicines Agency

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made bySanofi Pasteur
Active substanceCOVID-19 Vaccine (recombinant, adjuvanted)
Used inAntibiotics, antivirals and antifungals taken into the body
ClassificationJ07BN04 · Antibiotics, antivirals and antifungals taken into the body
Additional monitoring ▼Yes — under additional monitoring (black triangle). Report suspected side effects.
Authorised on2022-11-10
Last updated by the regulator2024-07-30
EMA product numberEMEA/H/C/005754

Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician

Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.